Loading...

Robotics And Healthcare Demand Will Expand Market Opportunities

Published
28 Aug 24
Updated
05 Sep 25
AnalystConsensusTarget's Fair Value
US$141.50
9.1% undervalued intrinsic discount
10 Sep
US$128.65
Loading
1Y
-25.6%
7D
21.9%

Author's Valuation

US$141.59.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on05 Sep 25

Novanta’s fair value outlook remains unchanged, as both the discount rate and future P/E shifted only marginally, leaving the consensus analyst price target steady at $141.50. What's in the News Novanta projects third quarter 2025 GAAP revenue of $244 million to $247 million and full year 2025 GAAP revenue of $970 million to $985 million.

Shared on07 May 25
Fair value Decreased 12%

Shared on30 Apr 25
Fair value Decreased 0.081%

AnalystConsensusTarget has decreased profit margin from 12.5% to 10.5% and increased future PE multiple from 50.2x to 59.6x.

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.23%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 5.17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Decreased 9.63%